436 related articles for article (PubMed ID: 30526305)
21. The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence.
Kortum RL; Johnson HJ; Costanzo DL; Volle DJ; Razidlo GL; Fusello AM; Shaw AS; Lewis RE
Mol Cell Biol; 2006 Mar; 26(6):2202-14. PubMed ID: 16507997
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved.
Vizioli MG; Santos J; Pilotti S; Mazzoni M; Anania MC; Miranda C; Pagliardini S; Pierotti MA; Gil J; Greco A
Oncotarget; 2014 Sep; 5(18):8270-83. PubMed ID: 25268744
[TBL] [Abstract][Full Text] [Related]
23. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
Sebastian T; Malik R; Thomas S; Sage J; Johnson PF
EMBO J; 2005 Sep; 24(18):3301-12. PubMed ID: 16107878
[TBL] [Abstract][Full Text] [Related]
24. p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase.
Zemskova M; Lilly MB; Lin YW; Song JH; Kraft AS
Mol Cancer Res; 2010 Aug; 8(8):1126-41. PubMed ID: 20647331
[TBL] [Abstract][Full Text] [Related]
25. RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress.
Wolyniec K; Wotton S; Kilbey A; Jenkins A; Terry A; Peters G; Stocking C; Cameron E; Neil JC
Oncogene; 2009 Jul; 28(27):2502-12. PubMed ID: 19448675
[TBL] [Abstract][Full Text] [Related]
26. Tiron protects against UVB-induced senescence-like characteristics in human dermal fibroblasts by the inhibition of superoxide anion production and glutathione depletion.
Fang Y; Hu XH; Jia ZG; Xu MH; Guo ZY; Gao FH
Australas J Dermatol; 2012 Aug; 53(3):172-80. PubMed ID: 22734867
[TBL] [Abstract][Full Text] [Related]
27. Cdk2: a key regulator of the senescence control function of Myc.
Hydbring P; Larsson LG
Aging (Albany NY); 2010 Apr; 2(4):244-50. PubMed ID: 20445224
[TBL] [Abstract][Full Text] [Related]
28. Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer.
Di Micco R; Sulli G; Dobreva M; Liontos M; Botrugno OA; Gargiulo G; dal Zuffo R; Matti V; d'Ario G; Montani E; Mercurio C; Hahn WC; Gorgoulis V; Minucci S; d'Adda di Fagagna F
Nat Cell Biol; 2011 Mar; 13(3):292-302. PubMed ID: 21336312
[TBL] [Abstract][Full Text] [Related]
29. IMR90 ER:RAS: A Cell Model of Oncogene-Induced Senescence.
Innes AJ; Gil J
Methods Mol Biol; 2019; 1896():83-92. PubMed ID: 30474842
[TBL] [Abstract][Full Text] [Related]
30. Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells.
Junk DJ; Cipriano R; Stampfer M; Jackson MW
PLoS One; 2013; 8(2):e53776. PubMed ID: 23390492
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.
Serrano M; Lin AW; McCurrach ME; Beach D; Lowe SW
Cell; 1997 Mar; 88(5):593-602. PubMed ID: 9054499
[TBL] [Abstract][Full Text] [Related]
32. Inhibition enhancer of zeste homologue 2 promotes senescence and apoptosis induced by doxorubicin in p53 mutant gastric cancer cells.
Bai J; Ma M; Cai M; Xu F; Chen J; Wang G; Shuai X; Tao K
Cell Prolif; 2014 Jun; 47(3):211-8. PubMed ID: 24738879
[TBL] [Abstract][Full Text] [Related]
33. Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence.
Brookes S; Gagrica S; Sanij E; Rowe J; Gregory FJ; Hara E; Peters G
Cell Cycle; 2015; 14(8):1164-73. PubMed ID: 25695870
[TBL] [Abstract][Full Text] [Related]
34. High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts.
Deng Q; Liao R; Wu BL; Sun P
J Biol Chem; 2004 Jan; 279(2):1050-9. PubMed ID: 14593117
[TBL] [Abstract][Full Text] [Related]
35. Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells.
Hasegawa H; Yamada Y; Iha H; Tsukasaki K; Nagai K; Atogami S; Sugahara K; Tsuruda K; Ishizaki A; Kamihira S
Leukemia; 2009 Nov; 23(11):2090-101. PubMed ID: 19710698
[TBL] [Abstract][Full Text] [Related]
36. p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts.
Carbone CJ; Graña X; Reddy EP; Haines DS
Cancer Res; 2007 May; 67(9):4130-7. PubMed ID: 17483323
[TBL] [Abstract][Full Text] [Related]
37. Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations.
Garbe JC; Vrba L; Sputova K; Fuchs L; Novak P; Brothman AR; Jackson M; Chin K; LaBarge MA; Watts G; Futscher BW; Stampfer MR
Cell Cycle; 2014; 13(21):3423-35. PubMed ID: 25485586
[TBL] [Abstract][Full Text] [Related]
38. Induction of cellular senescence by oncogenic RAS.
Gupta R; Wajapeyee N
Methods Mol Biol; 2013; 1048():127-33. PubMed ID: 23929102
[TBL] [Abstract][Full Text] [Related]
39. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.
Udden SM; Morita-Fujimura Y; Satake M; Ikawa S
Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958
[TBL] [Abstract][Full Text] [Related]
40. Induction of p38δ expression plays an essential role in oncogenic ras-induced senescence.
Kwong J; Chen M; Lv D; Luo N; Su W; Xiang R; Sun P
Mol Cell Biol; 2013 Oct; 33(19):3780-94. PubMed ID: 23878395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
